Alzamend Neuro Inc (ALZN) vs Basel Medical Group Ltd Ordinary Shares (BMGL)

A side-by-side comparison of Alzamend Neuro Inc and Basel Medical Group Ltd Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Alzamend Neuro Inc logo
ALZN
Alzamend Neuro Inc
$5M
$1.41HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Basel Medical Group Ltd Ordinary Shares logo
BMGL
Basel Medical Group Ltd Ordinary Shares
$5M
$3.17HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ALZN vs BMGL

growth of $100 · dividends reinvested · last 2y
ALZN -81.6% (-57.1%/yr)BMGL -94.1% (-75.6%/yr)ALZN compounded faster over this window
050100Start $1002026$18$6
ALZN BMGL

ALZN vs BMGL: by the numbers

  • •ALZN is the larger company ($5M vs $5M market cap).
  • •Both run net losses; ALZN's is the smaller (0.00% vs -106.78% net margin).

Metrics side by side

Valuation

MetricALZNBMGL
P/B ratio0.921.02

Profitability

MetricALZNBMGL
Gross margin0.00%77.68%
Operating margin0.00%-19.28%
Net margin0.00%-106.78%
ROE-156.77%-248.66%
ROIC-156.69%-35.07%

Growth (annualized)

MetricALZNBMGL
Total return CAGR (5Y)-79.14%N/A

Go deeper

Full ALZN analysisFull BMGL analysisInteractive comparison tool

Dig into the metrics

Alzamend Neuro ROEBasel Medical Group Ltd Ordinary Shares ROEAlzamend Neuro operating marginBasel Medical Group Ltd Ordinary Shares operating marginAlzamend Neuro revenue growthBasel Medical Group Ltd Ordinary Shares revenue growthAlzamend Neuro free cash flowBasel Medical Group Ltd Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.